Repuroising Of Fda Approved Thiothixine a Typical Antipychotic Agent as A Pde-5 Inhbitor For Erectile Dysfunction

Erectile dysfunction (ED) is a common disorder that affects men's physical and psychological health. The treatment of ED has evolved with the approval of new PDE-5 inhibitors such as sildenafil, which causes an erection through inhibition of the PDE-5 enzyme that regulates and maintains blood flow in the penis. Although PDE-5 inhibitors have shown efficacy in treating ED, approximately 30% of patients will not have a satisfactory response to these medications. In these patients, alternatives should be explored. Thiothixene is a first-generation antipsychotic primarily used to treat schizophrenia but has the potential to inhibit PDE-5 like its sibling drugs. Furthermore, thiothixene has been observed in some recent computational studies to cluster with previously recognized PDE-5 inhibitors and possibly treat ED. Furthermore, since thiothixene is non-invasive and safe, it may be an appropriate alternative to men with ED who have not.